Loading stock data…
Loading stock data…
US$5.36
Get one email when ACRS crosses your level. Checked every 15 minutes during market hours.
▼ -0.24 (-4.29%)down today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
56.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.25
Bearish momentumMACD below its signal line (0.26).
50-day average
4.82
Price aboveShort-term trend reference.
200-day average
3.54
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. It operates through two segments: Therapeutics, which identifies and advances innovative therapies to meet unmet needs in conditions such as atopic dermatitis, asthma, and alopecia areata, and Contract Research, which provides laboratory services. Key product candidates include ATI-2138, a potent and selective oral ITK/JAK3 inhibitor demonstrating …
www.aclaristx.com8 strong buy · 8 buy · 2 hold · 0 sell · 0 strong sell (18 analysts, 2026-07-01)
8 strong buy · 7 buy · 2 hold · 0 sell · 0 strong sell (17 analysts, 2026-06-01)
7 strong buy · 7 buy · 2 hold · 0 sell · 0 strong sell (16 analysts, 2026-05-01)
6 strong buy · 7 buy · 2 hold · 0 sell · 0 strong sell (15 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-04 | 0.78 | 0.87 | ✓ Beat |
| 2026-03-11 | 0.57 | 0.51 | ✗ Miss |
| 2026-02-26 | -0.14 | -0.16 | ✗ Miss |
| 2026-01-17 | 0.38 | 0.34 | ✗ Miss |
| 2025-11-06 | -0.14 | -0.12 | ✓ Beat |
| 2025-08-07 | -0.13 | -0.13 | ✓ Beat |
| 2025-05-08 | -0.12 | -0.12 | ✓ Beat |
Companies in the same industry, via Finnhub